PRASCEND 1 mg 160 Tablets (Horses)
Boehringer-Ingelheim |
100065

PRASCEND 1 mg 160 Tablets (Horses)

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description

PRASCEND, veterinarians most trusted treatment

PRASCEND is the most-proven treatment available to control the clinical signs associated with PPID in horses. Pituitary pars intermedia dysfunction (PPID), also referred to as equine Cushing's disease, is one of the most common endocrine disorders in horses. The signs are often subtle, but the disease can be serious.

Horses treated with PRASCEND:
CONTROLLED SIGNS: Clinical signs improved within 3 months and continued through 6 months.
PROVEN SUCCESS: Three out of four horses evaluated were considered treatment successes.
CLEAR IMPROVEMENT: Hypertrichosis (delayed shedding) improved in 89% of treated horses within 6 months.

PRASCEND tablets contain 1 mg pergolide for horses, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only.

PACK SIZE: 160 Tablets

Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Ingredients:
PRASCEND®
Categorisation:
Prescription